Sticta Biologicals
PrivateLast Round
Grant
Oct 28, 2024
Total Funding Raised
$140,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Sticta Biologicals is a biotechnology company that develops a microbial platform using precision fermentation to produce recombinant proteins and growth factors for the cultivated meat and biopharmaceutical industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sticta Biologicals Comparables
Compare Sticta Biologicals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Multus Biotechnology | 88% | |
| Immobazyme | 84% | |
| Defined Bioscience | 84% |
Sticta Biologicals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 28, 2024 | ||||
| Accelerator | Apr 1, 2023 |
Key People
Founding team and executive leadership
Sticta Biologicals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ProVeg Incubator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
Monthly visitors grew 196% MoM, reaching 2.9K.
Sticta Biologicals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Sticta Biologicals's valuation, stock price, and market status.
Is Sticta Biologicals a public or private company?
Sticta Biologicals is a private company.
What is the current stock price of Sticta Biologicals?
Sticta Biologicals is a private company with no public stock price. Caplight tracks Sticta Biologicals's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Sticta Biologicals worth (valuation)?
Valuation information for Sticta Biologicals is not publicly available.
Can I buy Sticta Biologicals stock?
Sticta Biologicals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Sticta Biologicals's last funding round?
Sticta Biologicals's most recent funding round was Grant on October 28, 2024.
Who are the main investors in Sticta Biologicals?
Key investors in Sticta Biologicals include ProVeg Incubator.
Will Sticta Biologicals IPO soon?
No public IPO plans have been announced for Sticta Biologicals.
How can I track Sticta Biologicals secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sticta Biologicals's secondary market activity and sign up for updates.